Copyright
©The Author(s) 2025.
World J Gastroenterol. Jul 14, 2025; 31(26): 106509
Published online Jul 14, 2025. doi: 10.3748/wjg.v31.i26.106509
Published online Jul 14, 2025. doi: 10.3748/wjg.v31.i26.106509
Table 5 Risk factor analysis
Parameters | Coefficient | SE | Wald | P value | OR | OR CI lower | OR CI upper |
Age (years) | 0.049 | 0.021 | 2.325 | 0.020 | 1.050 | 1.008 | 1.094 |
Gender (male/female) | 0.787 | 0.343 | 2.290 | 0.022 | 2.196 | 1.120 | 4.305 |
ICI | 0.485 | 0.350 | 1.386 | 0.166 | 1.624 | 0.818 | 3.223 |
CK-MB (μg/L) | 0.133 | 0.053 | 2.499 | 0.012 | 1.142 | 1.029 | 1.267 |
CK (U/L) | 0.024 | 0.009 | 2.681 | 0.007 | 1.025 | 1.007 | 1.043 |
QRS duration | 0.707 | 0.388 | 1.820 | 0.069 | 2.028 | 0.947 | 4.342 |
- Citation: Liu JY, Gao DL, Cao X. Risk factors and diagnostic biomarkers for asymptomatic immune checkpoint inhibitor-related myocarditis in patients with esophageal cancer after immunotherapy. World J Gastroenterol 2025; 31(26): 106509
- URL: https://www.wjgnet.com/1007-9327/full/v31/i26/106509.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i26.106509